跳至主要内容
临床试验/CTRI/2024/06/069209
CTRI/2024/06/069209尚未招募1 期

Comparison of efficacy between descemetorhexis without endothelial keratoplasty (DWEK) with or without topical rho kinase inhibitor in Fuch’s endothelial corneal dystrophy (FECD).

MAULANA AZAD MEDICAL COLLEGE1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年7月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
24
试验地点
1
主要终点
Change in central corneal thickness

研究概览

简要总结

This  study is a randomized, single blinded , clinical trial comparing the efficacy between descemetorhexis without endothelial keratoplasty (DWEK) with or without topical rho kinase inhibitor in fuch’s endothelial corneal dystrophy (FECD) that will be conducted in Guru nanak eye centre comprising 12 per group of sample. Primary outcome is change  in Central corneal thickness at 6 months and secondary outcome is change in endothelial cell count at central cornea and periphery at 6 months .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Adults with Fuchs dystrophy diagnosed clinically with cataract .
  • Dense central guttae limited to central 5mm of cornea .
  • Central stromal edema with visually significant complaints, morning blur .
  • Clear peripheral cornea with an endothelial cell count of more than 1000 cells / mm square .

排除标准

  • Advanced corneal edema defined as the presence of bullae or scarring .
  • Presence of secondary corneal pathology such as infective or autoimmune keratitis .
  • All patients with any retinal pathology ,advanced glaucoma corneal edema other than FECD.
  • Patients on hormonal therapy /Oral contraceptive pills.

结局指标

主要结局

Change in central corneal thickness

时间窗: Preop ,post op day 1 ,at 1 month ,then monthly till 6 months

次要结局

  • Change in endothelial cell count in central and periphery .(6 months)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Parul Jain

Guru Nanak Eye Centre

研究点 (1)

Loading locations...

相似试验